 |
- Abreva® provides cold sore/fever blister treatment on the face or lips
- Abreva is the only non-prescription cold sore medicine that is FDA approved to shorten healing time.
- In clinical trials, Abreva was shown to reduce cold sore healing time to a median of 4.1 days and was shown to eliminate symptoms of pain, burning, itching and tingling in just a median of 2.2 days.1
- Abreva is approved for use in adults and children 12 and over; no contraindications
Clinicals, Research and Data
Sacks SL, Thisted RA, Jones TM, et al. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis; a multicenter, randomized, placebo-controlled trial. J Am Acad Dermatol. 2001;45:222-230.
Patient Education
|
 |
For More Information
If you would like additional information about Abreva, please call:
1-877-709-3539.
Ask a Dental Professional
We're here to help. Professional answers to those tough questions.
Frequently Asked Questions
Search through our index of questions and answers.
|
 |